Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia M Wilting

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Cancers|April 30, 2021
Circular RNA in Chemonaive Lymph Node Negative Colon Cancer PatientsInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Oncotarget|June 9, 2016
Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independenceSaskia M Wilting, Viktorian Miok, Annelieke Jaspers, et al.
Genes, Chromosomes & Cancer|July 12, 2008
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancerSaskia M Wilting, Jillian de Wilde, Chris J L M Meijer, et al.
Molecular Oncology|September 12, 2021
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancerInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Molecular Oncology|December 6, 2018
High-throughput isolation of circulating tumor DNA: a comparison of automated platformsLisanne F van Dessel, Silvia R Vitale, Jean C A Helmijr, et al.
The British Journal of Surgery|April 12, 2026
Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohortLissa Wullaert, Lotte van Leeuwen, Vanja de Weerd, et al.
Frontiers in Oncology|February 16, 2023
Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analysesJan M van Rees, Lissa Wullaert, Alexander A J Grüter, et al.
NPJ Breast Cancer|July 14, 2023
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survivalNoortje Verschoor, Vanja de Weerd, Mai N Van, et al.
Molecular Oncology|December 29, 2021
A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneityTeoman Deger, Pauline A J Mendelaar, Jaco Kraan, et al.
Cancers|March 11, 2023
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful WaitingManouk K Bos, Sarah R Verhoeff, Sjoukje F Oosting, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Cancers|April 30, 2021
Circular RNA in Chemonaive Lymph Node Negative Colon Cancer PatientsInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Oncotarget|June 9, 2016
Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independenceSaskia M Wilting, Viktorian Miok, Annelieke Jaspers, et al.
Genes, Chromosomes & Cancer|July 12, 2008
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancerSaskia M Wilting, Jillian de Wilde, Chris J L M Meijer, et al.
Molecular Oncology|September 12, 2021
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancerInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Molecular Oncology|December 6, 2018
High-throughput isolation of circulating tumor DNA: a comparison of automated platformsLisanne F van Dessel, Silvia R Vitale, Jean C A Helmijr, et al.
The British Journal of Surgery|April 12, 2026
Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohortLissa Wullaert, Lotte van Leeuwen, Vanja de Weerd, et al.
Frontiers in Oncology|February 16, 2023
Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analysesJan M van Rees, Lissa Wullaert, Alexander A J Grüter, et al.
NPJ Breast Cancer|July 14, 2023
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survivalNoortje Verschoor, Vanja de Weerd, Mai N Van, et al.
Molecular Oncology|December 29, 2021
A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneityTeoman Deger, Pauline A J Mendelaar, Jaco Kraan, et al.
Cancers|March 11, 2023
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful WaitingManouk K Bos, Sarah R Verhoeff, Sjoukje F Oosting, et al.
Pageof 9